• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma].

作者信息

Klee M, Illiger H J

出版信息

Strahlenther Onkol. 2001 Sep;177(9):494-5. doi: 10.1007/BF03353387.

DOI:10.1007/BF03353387
PMID:11591024
Abstract
摘要

相似文献

1
[IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma].
Strahlenther Onkol. 2001 Sep;177(9):494-5. doi: 10.1007/BF03353387.
2
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.强化化疗后干扰素α巩固治疗不能延长低度非霍奇金淋巴瘤患者的无进展生存期：西南肿瘤协作组随机III期研究8809的结果
J Clin Oncol. 2000 May;18(10):2010-6. doi: 10.1200/JCO.2000.18.10.2010.
3
Role of interferon-alfa in NHL: still controversial?α干扰素在非霍奇金淋巴瘤中的作用：仍存在争议？
Oncology (Williston Park). 1999 Aug;13(8):1147-59; discussion 1159-60, 1163.
4
Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.人重组干扰素α-2a维持Ⅲ期和Ⅳ期低度恶性非霍奇金淋巴瘤患者的缓解状态。欧洲癌症研究与治疗组织淋巴瘤协作组
J Clin Oncol. 1998 Jan;16(1):41-7. doi: 10.1200/JCO.1998.16.1.41.
5
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimen.对采用干扰素α（IFN-α2a）加蒽环类诱导方案治疗的非霍奇金淋巴瘤患者进行的ECOG I-COPA试验（E6484）的最终分析。
Leukemia. 2001 Jul;15(7):1118-22. doi: 10.1038/sj.leu.2402161.
6
Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
Leuk Lymphoma. 1996 Feb;20(5-6):495-9. doi: 10.3109/10428199609052435.
7
Meta-analysis to evaluate the role of interferon in follicular lymphoma.评估干扰素在滤泡性淋巴瘤中作用的荟萃分析。
J Clin Oncol. 2005 Apr 1;23(10):2215-23. doi: 10.1200/JCO.2005.06.146. Epub 2005 Jan 31.
8
Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.用苯丁酸氮芥交替联合干扰素及放疗治疗难治性低度淋巴瘤。
Cancer Biother. 1995 Winter;10(4):273-7. doi: 10.1089/cbr.1995.10.273.
9
Long-term results in patients with low-grade nodular non-Hodgkin's lymphoma. A randomized trial comparing chemotherapy plus radiotherapy with chemotherapy alone.低度结节性非霍奇金淋巴瘤患者的长期结果。一项比较化疗加放疗与单纯化疗的随机试验。
Acta Oncol. 1991;30(3):329-33. doi: 10.3109/02841869109092380.
10
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.I-II期惰性非霍奇金淋巴瘤综合治疗前瞻性研究的长期随访
J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111.

本文引用的文献

1
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.强化化疗后干扰素α巩固治疗不能延长低度非霍奇金淋巴瘤患者的无进展生存期：西南肿瘤协作组随机III期研究8809的结果
J Clin Oncol. 2000 May;18(10):2010-6. doi: 10.1200/JCO.2000.18.10.2010.
2
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.含多柔比星方案联合或不联合α-2b干扰素治疗晚期滤泡性淋巴瘤：滤泡性淋巴瘤研究组86试验的生存及毒性最终分析
J Clin Oncol. 1998 Jul;16(7):2332-8. doi: 10.1200/JCO.1998.16.7.2332.
3
Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
Leuk Lymphoma. 1996 Feb;20(5-6):495-9. doi: 10.3109/10428199609052435.
4
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.重组干扰素α-2b联合含阿霉素方案治疗晚期滤泡性淋巴瘤。成人淋巴瘤研究组。
N Engl J Med. 1993 Nov 25;329(22):1608-14. doi: 10.1056/NEJM199311253292203.
5
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.干扰素α联合细胞毒性化疗用于非霍奇金淋巴瘤患者
N Engl J Med. 1992 Nov 5;327(19):1336-41. doi: 10.1056/NEJM199211053271902.